|
|
|
|
Direct Cost |
Indirect Cost |
|
1F31DA054702-01 |
Resisting food temptation: how do affective and cognitive brain systems interact? |
UNIVERSITY OF TX MD ANDERSON CAN CTR |
NIDA |
$33,533 |
|
$33,533 |
1F31DE031502-01 |
Multiparametric Magnetic Resonance Imaging Artificial Intelligence Pipeline for Oropharyngeal Cancer Radiotherapy Treatment Guidance |
UNIVERSITY OF TX MD ANDERSON CAN CTR |
NIDCR |
$43,436 |
|
$43,436 |
1F31HD106600-01 |
Gene Regulatory Networks for Mullerian Duct Regression |
UNIVERSITY OF TX MD ANDERSON CAN CTR |
NICHD |
$33,533 |
|
$33,533 |
1F31NS124110-01 |
Novel Role of Peroxisome Proliferator Activated Receptor Beta/Delta in X-Linked Adrenoleukodystrophy |
UNIVERSITY OF TX MD ANDERSON CAN CTR |
NINDS |
$33,530 |
|
$33,530 |
1F32CA253780-01A1 |
INVESTIGATING THE ROLE OF HSP90 IN SHAPING THE CONSEQUENCES OF BRCA1 MUTATIONS |
UNIVERSITY OF TX MD ANDERSON CAN CTR |
NCI |
$68,562 |
|
$68,562 |
1F32CA260769-01 |
Elucidating the role of gut, blood, and tumor microbiota in brain metastasis |
UNIVERSITY OF TX MD ANDERSON CAN CTR |
NCI |
$65,994 |
|
$65,994 |
1K01AI163412-01 |
Immune-Related Adverse Events in Melanoma Patients Receiving Adjuvant Immune Checkpoint Inhibitor Therapy |
UNIVERSITY OF TX MD ANDERSON CAN CTR |
NIAID |
$105,433 |
$8,435 |
$113,868 |
1K08AR079587-01 |
Characterization of altered immunity in patients with inflammatory arthritis induced by immune checkpoint inhibitor therapy |
UNIVERSITY OF TX MD ANDERSON CAN CTR |
NIAMS |
$158,000 |
$12,640 |
$170,640 |
1K08CA263313-01 |
Impact of clonal hematopoiesis mutations on toxicity and outcomes following oncologic therapy |
UNIVERSITY OF TX MD ANDERSON CAN CTR |
NCI |
$239,408 |
$19,153 |
$258,561 |
1K99CA249048-01A1 |
A pro-metastatic secretory program activated by epithelial-to-mesenchymal transition |
UNIVERSITY OF TX MD ANDERSON CAN CTR |
NCI |
$103,612 |
$8,289 |
$111,901 |
1K99CA255936-01 |
Mechanisms of translational output control in pancreatic cancer |
UNIVERSITY OF TX MD ANDERSON CAN CTR |
NCI |
$103,544 |
$8,284 |
$111,828 |
1K99CA256216-01 |
Multilevel investigation of uncertain and reclassified genomic variants in clinical oncology |
UNIVERSITY OF TX MD ANDERSON CAN CTR |
NCI |
$99,879 |
$7,990 |
$107,869 |
1K99HL155845-01 |
Mechanism of pulmonary endothelial cell heterogeneity and its role in disease |
UNIVERSITY OF TX MD ANDERSON CAN CTR |
NHLBI |
$96,800 |
$7,744 |
$104,544 |
1K99MD015296-01A1 |
Social determinants of sleep and obesity: Disparities in African Americans |
UNIVERSITY OF TX MD ANDERSON CAN CTR |
NIMHD |
$90,542 |
$7,243 |
$97,785 |
1R01AG067419-01A1 |
Alzheimers Disease Pathology in a Primate Model |
UNIVERSITY OF TX MD ANDERSON CAN CTR |
NIA |
$669,632 |
$138,023 |
$807,655 |
1R01AI155582-01A1 |
Neutrophil Extracellular Traps and Host Immunity |
UNIVERSITY OF TX MD ANDERSON CAN CTR |
NIAID |
$250,000 |
$155,000 |
$405,000 |
1R01AR078484-01A1 |
Effects of biologic and targeted therapies for rheumatoid arthritis on cancer outcomes |
UNIVERSITY OF TX MD ANDERSON CAN CTR |
NIAMS |
$132,000 |
$81,840 |
$213,840 |
1R01CA231509-01A1 |
Pro-Drug Enolase Inhibitors in Precision Oncology |
UNIVERSITY OF TX MD ANDERSON CAN CTR |
NCI |
$203,499 |
$126,169 |
$329,668 |
1R01CA236905-01A1 |
Molecular Understanding and Targeting of Determinant Factors in Gastric Tumorigenesis |
UNIVERSITY OF TX MD ANDERSON CAN CTR |
NCI |
$228,750 |
$141,825 |
$370,575 |
1R01CA240839-01A1 |
Functional characterization and rational therapeutic targeting of 18q DNA copy number gains in diffuse large B-cell lymphoma |
UNIVERSITY OF TX MD ANDERSON CAN CTR |
NCI |
$272,180 |
$168,752 |
$440,932 |